OR WAIT null SECS
© 2021 MJH Life Sciences and Modern Retina. All rights reserved.
© 2021 MJH Life Sciences™ and Modern Retina. All rights reserved.
July 26, 2021
Following a discussion regarding drug delivery challenges in retinal disease, a panel of global experts suggest what types of technological requirements and improvements they would like to see occur in the field.
Challenges associated with delivering therapies currently available to treat retinal disorders and methods being explored to improve drug delivery to patients.
July 20, 2021
Dual imaging may reduce costs, unnecessary referrals, telehealth study results show.
July 19, 2021
Drawbacks and challenges associated with the administration of anti-VEGF injections currently available to treat retinal diseases.
Dr Mariya Moosajee highlights therapies approved as well as under study to improve treatment for patients with inherited retinal disease.
July 15, 2021
Promoting Tie2 signaling activity may complement inhibition of VEGF in addressing pathology in disease states characterized by angiogenesis, vascular permeability, and inflammation.
July 12, 2021
A discussion regarding the roles of various treatments available for diabetic macular edema and considerations for selecting and sequencing therapy.
An overview of the current treatment landscape for age-related macular degeneration and factors that impact treatment selection.
June 30, 2021
Types of tests and criteria that can be used to diagnose conditions such as age-related macular degeneration, diabetic macular edema, and inherited retinal disease.
A panel of global experts who treat patients with retinal diseases suggest causes of age-related macular degeneration, diabetic macular edema, and inherited retinal disease.